Health & Medicine
- Health & Medicine
What you need to know about the new omicron booster shots
With approval of omicron booster shots, COVID-19 vaccine approval and dosing guidance is moving closer to the way flu shots are handled.
- Health & Medicine
Who has the highest risk of long COVID? It’s complicated
Long COVID can look different for different people, making it difficult to pinpoint the risk factors behind it.
- Health & Medicine
The curious case of the 471-day coronavirus infection
One patient couldn’t get rid of their coronavirus infection. The case gave scientists an unprecedented look at viral evolution.
By Meghan Rosen - Tech
50 years ago, genes eluded electron microscopes
In the 1970s, scientists dreamed of seeing genes under the microscope. Fifty years later, powerful new tools are helping to make that dream come true.
By Nikk Ogasa - Health & Medicine
The new CDC guidelines may make back-to-school harder
The public health agency’s coronavirus advice could change how schools operate and may spur COVID-19 outbreaks in classrooms.
By Meghan Rosen - Health & Medicine
The first known monkeypox infection in a pet dog hints at spillover risk
A person passed monkeypox to a dog. Other animals might be next, allowing the virus to set up shop outside of Africa for the first time.
- Health & Medicine
COVID-19 infections can rebound for some people. It’s unclear why
Rebounding COVID-19 isn’t limited to Paxlovid patients. An infection can come back even for people not given the drug.
- Health & Medicine
50 years ago, scientists hoped freezing donor organs would boost transplants
In the 1970s, biologists hoped to freeze organs so more could last long enough to be transplanted. Scientists are now starting to manage this feat.
By Asa Stahl - Chemistry
These researchers are unlocking Renaissance beauty secrets
An art historian has teamed up with chemists to uncover the science behind cosmetics used around 500 years ago.
- Health & Medicine
Multiple sclerosis has a common viral culprit, opening doors to new approaches
Learning how the common Epstein-Barr virus may trigger multiple sclerosis could help experts design better treatments — or perhaps end the disease.
- Health & Medicine
A shot of immune proteins may protect against malaria for months
A monoclonal antibody for malaria passed an early hurdle and now will be tested in children in Africa, who are most at risk of dying from the disease.
- Health & Medicine
Tiny amoebas move faster when carrying cargo than without
A new study of the carrying capacity of single-celled amoebas may help scientists develop mini “trucks” to precisely target disease in the human body.